University of California, San Francisco School of Medicine, 505 Parnassus Ave, San Francisco, CA, 94143, United States.
Department of Community Health Systems, School of Nursing, University of California, San Francisco 2 Koret Way, N 531E, Box 0608, San Francisco, CA, 94143, United States.
BMC Nephrol. 2023 May 1;24(1):119. doi: 10.1186/s12882-023-03174-6.
Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach.
Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes.
Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model.
These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions.
对于常染色体显性多囊肾病(ADPKD)患者而言,肾移植是肾脏替代治疗的金标准,该病是导致肾衰竭的第四大病因。尽管在移植前进行透析的抢先肾移植具有医学和经济效益,但只有 9-21%的合格患者接受抢先移植。鉴于抢先移植的比率较低,本研究旨在采用定性方法确定 ADPKD 患者对抢先移植的感知促进因素和障碍。
2021 年 7 月至 2022 年 1 月,通过虚拟个人半结构化访谈,对 16 名成年 ADPKD 患者进行了数据收集。对记录的访谈进行定性分析,以生成主题。
我们的研究结果揭示了两个抢先移植的促进因素主题(社会支持和患者能动性)和三个抢先移植的障碍主题(社会支持不足、知识差距以及机构和系统政策)。研究结果还包括各种子主题以及这些主题在社会生态模型中的应用。
这些发现表明,增加社会支持和患者能动性,例如通过患者导航员计划,并鼓励医疗保健提供者与患者之间进行有效的沟通,可以促进移植过程。通过配对肾脏交换教育和活体供体外联,从机构和系统向患者传播更多的移植知识,也可以增加 ADPKD 患者及时获得抢先肾移植的机会。我们的研究结果受到了来自美国单站点研究的限制,这些结果可能不适用于经历不同社会、文化和健康条件的个体。